Table 2 Parameters related to final BCVA in the peeling group.
Parameter | Improved or stable (n = 19) | Worsened (n = 12) | P-value |
---|---|---|---|
ERM stage at baseline | |||
1 | 4 (21) | 2 (17) | |
2 | 7 (37) | 3 (25) | |
3 | 4 (21) | 6 (50) | |
4 | 4 (21) | 1 (8) | 0.488 |
Surgical procedure during PPV | |||
25-gauge (%) | 12 (63) | 9 (75) | |
27-gauge (%) | 7 (37) | 3 (25) | 0.697 |
Preoperative PVD (%) | 15 (79) | 9 (75) | 0.798 |
Phakic (%) | 18 (95) | 6 (50) | 0.007 |
Cataract surgery (%) | 18 (95) | 5 (42) | 0.002 |
Intentional ILM peeling (%) | 16 (84) | 10 (83) | 0.948 |
ILM visualization | |||
TA (%) | 15 (78) | 10 (84) | |
ICG (%) | 2 (11) | 1 (8) | |
BBG (%) | 2 (11) | 1 (8) | 0.956 |
DONFL (%) | 3 (16) | 2 (17) | 0.948 |
Intravitreal air tamponade during PPV (%) | 0 (0) | 1 (8) | 0.201 |
Presence of macular pucker (%) | 3 (16) | 1 (8) | 0.546 |
Postoperative follow-up period (months) | 49.05 ± 20.01 | 39.92 ± 12.02 | 0.166 |
Central visual field defect within 10 degrees at baseline | 9 (47) | 5 (42) | 0.756 |
CFT at baseline | 379.2 ± 122.9 | 300.7 ± 115.7 | 0.087 |
CFT at final visit | 244.6 ± 70.6 | 223.2 ± 39.5 | 0.347 |
GCC at baseline | 136.8 ± 36.9 | 112.5 ± 28.5 | 0.063 |
GCC at final visit | 99.0 ± 24.7 | 100.9 ± 19.5 | 0.818 |
MME at baseline (%) | 5 (26) | 5 (42) | 0.376 |
MME at final visit (%) | 2 (11) | 2 (17) | 0.630 |